Emerging targeted drug delivery strategies toward ovarian cancer

2021 ◽  
Vol 178 ◽  
pp. 113969
Author(s):  
Zhe Wang ◽  
Fenghua Meng ◽  
Zhiyuan Zhong
Author(s):  
Emrullah Korkmaz ◽  
Stephen C. Balmert ◽  
Cara Donahue Carey ◽  
Geza Erdos ◽  
Louis D. Falo

Theranostics ◽  
2019 ◽  
Vol 9 (3) ◽  
pp. 778-795 ◽  
Author(s):  
Minati Satpathy ◽  
Liya Wang ◽  
Rafal J. Zielinski ◽  
Weiping Qian ◽  
Y. Andrew Wang ◽  
...  

2009 ◽  
Vol 7 (suppl_1) ◽  
Author(s):  
Wiebke Ulbrich ◽  
Alf Lamprecht

Limitations in therapy induced by adverse effects due to unselective drug availability and therefore the use of potentially too high doses are a common problem. One prominent example for this dilemma are inflammatory diseases. Colloidal carriers allow one to improve delivery of drugs to the site of action and appear promising to overcome this general therapeutic drawback. Specific uptake of nanoparticles by immune-related cells in inflamed barriers offers selective drug targeting to the inflamed tissue. Here we focus on nanocarrier-based drug delivery strategies for the treatment of common inflammatory disorders like rheumatoid arthritis, multiple sclerosis, uveitis or inflammatory bowel disease.


2014 ◽  
Vol 4 (3) ◽  
pp. 193-201 ◽  
Author(s):  
Xiaoli Wei ◽  
Xishan Chen ◽  
Man Ying ◽  
Weiyue Lu

2014 ◽  
pp. 1223 ◽  
Author(s):  
Claudia Marchetti ◽  
Margherita Giorgini ◽  
Caterina De Medici ◽  
Innocenza Palaia ◽  
Roberta Iadarola ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document